Open Access<p>Changes in Serum Nesfatin-1 After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Nonalcoholic Fatty Liver Disease</p>
Author(s) -
Keda Yang,
Xiaowei Zhang,
Yong Zhou,
Caixia Fu,
Mingyang Shen,
Yong Wang
Publication year - 2020
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s246281
Subject(s) - medicine , nonalcoholic fatty liver disease , steatosis , gastroenterology , sleeve gastrectomy , fatty liver , body mass index , weight loss , surgery , disease , obesity , gastric bypass
Nonalcoholic fatty liver disease (NAFLD) is a serious and widespread disease worldwide. Bariatric surgery is one of the treatments for NAFLD. Nesfatin-1 is located in the brain, periphery and plasma. We studied the relationship between nesfatin-1 changes after laparoscopic sleeve gastrectomy (LSG) and NAFLD remission.